Treating Children and Adolescents with Selective Serotonin Reuptake Inhibitors: How Long Is Appropriate?
The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
This article addresses a key question on the use of selective serotonin reuptake inhibitors (SSRIs) among children and adolescents. As briefly reviewed, recent randomized controlled trials have established the safety and efficacy of SSRIs in the acute treatment of major depression and anxiety disorders among children and adolescents. Major questions emerge in light of these data concerning the potential risks and benefits of long-term SSRI use among children and adolescents who receive significant short-term benefits from SSRI treatment. The current review summarizes research on longitudinal outcomes, neuroscience, and psychopharmacology to formulate a set of preliminary recommendations on long-term SSRI use. A review of data in these areas supports three conclusions. First, for children who achieve marked reduction in anxiety or depressive symptoms on an SSRI, clinicians should consider recommending a medication-free trial. Second, when indicated, this medication-free trial should coincide with the first low-stress period occurring after 1 year of continual SSRI treatment. Third, SSRI treatment should be reinitiated in children who exhibit signs of relapse during this medication-free trial.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Results of double-blind trials of SSRIs have been more compelling in adolescents ( 51), but the effect sizes vary widely, with possibly better responses with fluoxetine (52).”
From Pediatric psychopharmacology: Too much or too little? (2013) · cites this paper as [51]
Citations
Cites
Psychopharmacology: The Fourth Generation of Progress
Bloom, F. E., & Kupfer, D. J. (1995) · Medical Entomology and Zoology · Cited by 2,985
Meaney, M. J. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1161 · Cited by 2,708
Pine, D. S., Cohen, P., Gurley, D., Brook, J., & Ma, Y. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.1.56 · Cited by 1,753
Self-citationPlotsky, P. M., & Meaney, M. J. (1993) · Molecular Brain Research · doi:10.1016/0169-328x(93)90189-v · Cited by 1,638
Emslie, G. J. (1997) · Archives of General Psychiatry · doi:10.1001/archpsyc.1997.01830230069010 · Cited by 985
Depressed Adolescents Grown Up
Weissman, M. M. (1999) · JAMA · doi:10.1001/jama.281.18.1707 · Cited by 952
Adult Outcomes of Childhood and Adolescent Depression: I. Psychiatric Status
Harrington, R. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810170065010 · Cited by 764
Kovacs, M. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790140019002 · Cited by 712
Newman, D. L., Moffitt, T. E., Caspi, A., Magdol, L., Silva, P. A., & Stanton, W. R. (1996) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.64.3.552 · Cited by 682
PSYCHONEUROENDOCRINOLOGY OF DEPRESSION
Plotsky, P. M., Owens, M. J., & Nemeroff, C. B. (1998) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70006-x · Cited by 672 · cited 1×
“Work from Meaney, Plotsky, and others has extended these findings over the past 2 decades (Meaney 2001a, 2001b; Plot-sky and Meaney 1993; Plotsky et al. 1998).”
Cited by
Connolly, S. D., & Bernstein, G. A. (2007) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/01.chi.0000246070.23695.06 · Cited by 548
Social anxiety disorder: questions and answers for the DSM-V
Bögels, S. M., Alden, L., Beidel, D. C., Clark, L. A., Pine, D. S., Stein, M. B., & Voncken, M. (2010) · Depression and Anxiety · doi:10.1002/da.20670 · Cited by 526
Self-citationAssessment and Treatment of Anxiety Disorders in Children and Adolescents
Wehry, A. M., Beesdo-Baum, K., Hennelly, M. M., Connolly, S. D., & Strawn, J. R. (2015) · Current Psychiatry Reports · doi:10.1007/s11920-015-0591-z · Cited by 294
Challenges in Developing Novel Treatments for Childhood Disorders: Lessons from Research on Anxiety
Pine, D. S., Helfinstein, S. M., Bar-Haim, Y., Nelson, E., & Fox, N. A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.113 · Cited by 194
Self-citationPractice Parameter on the Use of Psychotropic Medication in Children and Adolescents
Walkup, J. (2009) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/chi.0b013e3181ae0a08 · Cited by 173
Metadata
- Authors
- Pine, D. S.
- Affiliations
- National Institute of Mental Health (US)
- Corresponding author
- Pine, Daniel S.
- ORCID
- Pine, Daniel S.
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2002-09
- Volume
- 12
- Issue
- 3
- Pages
- 189-203
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W1984463057
- Cited by
- 73
- References
- 79
- Citations by year
- 2026: 1 · 2025: 1 · 2023: 2 · 2020: 2 · 2019: 2 · 2018: 2 · 2017: 3 · 2016: 4 · 2015: 4 · 2014: 1 · 2013: 2 · 2012: 3
- FWCI
- 0.57
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.liebertpub.com/nv/resources-tools/text-and-data-mining-policy/121/ (tdm)
- Locations
- Journal of Child and Adolescent Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Child and Adolescent Psychosocial and Emotional Development
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- selective serotonin reuptake inhibitors, children and adolescents, relapse prevention, childhood depression, childhood anxiety disorders
- MeSH terms
- Adolescent, Animals, Anxiety Disorders, Child, Child, Preschool, Depressive Disorder, Drug Administration Schedule, Humans, Randomized Controlled Trials as Topic, Selective Serotonin Reuptake Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treating Children and Adolescents with Selective Serotonin Reuptake Inhibitors: How Long Is Appropriate? https://app.cochat.ai/papers/10.1089/104454602760386888
- The paper
- Pine, D. S. (2002). Treating Children and Adolescents with Selective Serotonin Reuptake Inhibitors: How Long Is Appropriate? Journal of Child and Adolescent Psychopharmacology. https://doi.org/10.1089/104454602760386888
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.